Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWolf Minerals Regulatory News (WLFE)

  • There is currently no data for WLFE

Appendix 5B

28 Jul 2017 07:00

RNS Number : 3704M
Wolf Minerals Limited
28 July 2017
 

+Rule 5.5

Appendix 5B

Mining exploration entity and oil and gas exploration entity quarterly report

Introduced 01/07/96 Origin Appendix 8 Amended 01/07/97, 01/07/98, 30/09/01, 01/06/10, 17/12/10, 01/05/13, 01/09/16

 

Name of entity

WOLF MINERALS LIMITED

ABN

 

Quarter ended ("current quarter")

11 121 831 472

 

30 JUNE 2017

 

Consolidated statement of cash flows

Current quarter $A'000

Year to date (12 months)$A'000

1.

Cash flows from operating activities

6,746

23,407

1.1

Receipts from customers

1.2

Payments for

-

-

 

(a) exploration & evaluation

 

(b) development

(3,952)

(17,708)

 

(c) production

(11,551)

(48,768)

 

(d) staff costs

(2,333)

(9,942)

 

(e) administration and corporate costs

(1,063)

(3,424)

1.3

Dividends received (see note 3)

-

-

1.4

Interest received

(5)

255

1.5

Interest and other costs of finance paid

(5,482)

(20,331)

1.6

Income taxes paid

-

-

1.7

Research and development refunds

1,302

1,302

1.8

Other (provide details if material)

-

-

1.9

Net cash from / (used in) operating activities

(16,338)

(75,209)

 

2.

Cash flows from investing activities

(0)

(133)

2.1

Payments to acquire:

 

(a) property, plant and equipment

 

(b) tenements (see item 10)

-

-

 

(c) investments

-

-

 

(d) other non-current assets

-

-

2.2

Proceeds from the disposal of:

-

-

 

(a) property, plant and equipment

 

(b) tenements (see item 10)

-

-

 

(c) investments

-

-

 

(d) other non-current assets

-

-

2.3

Cash flows from loans to other entities

-

-

2.4

Dividends received (see note 3)

-

-

2.5

Other (provide details if material)

-

-

2.6

Net cash from / (used in) investing activities

(0)

(133)

 

3.

Cash flows from financing activities

-

-

3.1

Proceeds from issues of shares

3.2

Proceeds from issue of convertible notes

-

-

3.3

Proceeds from exercise of share options

-

-

3.4

Transaction costs related to issues of shares, convertible notes or options

(4)

(41)

3.5

Proceeds from borrowings

16,934

55,525

3.6

Repayment of borrowings

-

(4,673)

3.7

Transaction costs related to loans and borrowings

(294)

(550)

3.8

Dividends paid

-

-

3.9

Other (provide details if material)

-

-

3.10

Net cash from / (used in) financing activities

16,636

50,261

 

4.

Net increase / (decrease) in cash and cash equivalents for the period

 

 

7,706

 

 

35,010

4.1

Cash and cash equivalents at beginning of period

4.2

Net cash from / (used in) operating activities (item 1.9 above)

(16,338)

(75,209)

4.3

Net cash from / (used in) investing activities (item 2.6 above)

(0)

(133)

4.4

Net cash from / (used in) financing activities (item 3.10 above)

16,636

50,261

4.5

Effect of movement in exchange rates on cash held

330

(1,595)

4.6

Cash and cash equivalents at end of period

8,334

8,334

 

5.

Reconciliation of cash and cash equivalentsat the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts

Current quarter$A'000

Previous quarter$A'000

5.1

Bank balances

8,256

7,628

5.2

Call deposits

78

78

5.3

Bank overdrafts

5.4

Other (provide details)

5.5

Cash and cash equivalents at end of quarter (should equal item 4.6 above)

8,334

7,706

 

6.

Payments to directors of the entity and their associates

Current quarter$A'000

6.1

Aggregate amount of payments to these parties included in item 1.2

121

6.2

Aggregate amount of cash flow from loans to these parties included in item 2.3

-

6.3

Include below any explanation necessary to understand the transactions included in items 6.1 and 6.2

 

1. Payment of directors remuneration.

 

 

7.

Payments to related entities of the entity and their associates

Current quarter$A'000

7.1

Aggregate amount of payments to these parties included in item 1.2

-

7.2

Aggregate amount of cash flow from loans to these parties included in item 2.3

-

7.3

Include below any explanation necessary to understand the transactions included in items 7.1 and 7.2

 

 

 

 

8.

Financing facilities availableAdd notes as necessary for an understanding of the position

Total facility amount at quarter end$A'000

Amount drawn at quarter end$A'000

8.1

Loan facilities

67,736

55,882

8.2

Credit standby arrangements

8.3

Other

8.4

Include below a description of each facility above, including the lender, interest rate and whether it is secured or unsecured. If any additional facilities have been entered into or are proposed to be entered into after quarter end, include details of those facilities as well.

£40 million (~A$68 million) Bridge Loan facility with Resource Capital Fund VI L.P. as announced on 24 October 2016, 13 March 2017 and 29 June 2017. The applicable interest rates is 4.25% + LIBOR.

£5 million (~A$8.5 million) uncommitted Bridge Loan facility with Resource Capital Fund VI L.P as announced on 29 June 2017. The applicable interest rates is 4.25% + LIBOR.

 

9.

Estimated cash outflows for next quarter

$A'000

9.1

Exploration and evaluation

-

9.2

Development

10,000

9.3

Production

16,500

9.4

Staff costs

2,500

9.5

Administration and corporate costs

1,000

9.6

Other (interest & finance costs)

4,000

9.7

Total estimated cash outflows

34,000

 

10.

Changes in tenements(items 2.1(b) and 2.2(b) above)

Tenement reference and location

Nature of interest

Interest at beginning of quarter

Interest at end of quarter

10.1

Interests in mining tenements and petroleum tenements lapsed, relinquished or reduced

N/A

N/A

 

 

10.2

Interests in mining tenements and petroleum tenements acquired or increased

N/A

N/A

 

 

 

Compliance statement

1 This statement has been prepared in accordance with accounting standards and policies which comply with Listing Rule 19.11A.

2 This statement gives a true and fair view of the matters disclosed.

 

Sign here: RICHARD LUCAS Date: 28 July 2017

(Interim Managing Director)

 

Print name: RICHARD LUCAS

 

Notes

1. The quarterly report provides a basis for informing the market how the entity's activities have been financed for the past quarter and the effect on its cash position. An entity that wishes to disclose additional information is encouraged to do so, in a note or notes included in or attached to this report.

2. If this quarterly report has been prepared in accordance with Australian Accounting Standards, the definitions in, and provisions of, AASB 6: Exploration for and Evaluation of Mineral Resources and AASB 107: Statement of Cash Flows apply to this report. If this quarterly report has been prepared in accordance with other accounting standards agreed by ASX pursuant to Listing Rule 19.11A, the corresponding equivalent standards apply to this report.

3. Dividends received may be classified either as cash flows from operating activities or cash flows from investing activities, depending on the accounting policy of the entity.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGUBWMUPMPGM
Date   Source Headline
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:01 amRNSAppendix 3Y
30th Jun 20177:01 amRNSIssue of Equity and Change of Directors' Interests
29th Jun 20179:15 amRNSReplacement of Grant of ASX Listing Rule Waivers
28th Jun 20173:15 pmRNSASX Listing Waivers for Bridge Facility Increase
28th Jun 20173:15 pmRNSBridge Facility with RCF Increased
16th Jun 20177:00 amRNSIssue of Equity
16th Jun 20177:00 amRNSAppendix 3B
16th May 20177:00 amRNSCancellation of Lapsed Performance Rights
15th May 20179:05 amRNSAppendix 3Z
15th May 20179:05 amRNSResignation of Director
8th May 20177:00 amRNSAppendix 3X
8th May 20177:00 amRNSInterim MD, Richard Lucas, Appointed to Wolf Board
28th Apr 20177:00 amRNSAppendix 5B
28th Apr 20177:00 amRNSQuarterly Activities Report
7th Apr 201710:19 amRNSDirectorate Change
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSIssue of Equity and Change of Directors' Interests
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSCleansing Notice Letter
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSAppendix 3B
4th Apr 20177:00 amRNSAppendix 3Y
16th Mar 20177:02 amRNSInterim Financial Statements
13th Mar 20177:35 amRNSUpdate on Bridge Facility with RCF
20th Feb 20174:41 pmRNSSecond Price Monitoring Extn
20th Feb 20174:35 pmRNSPrice Monitoring Extension
10th Feb 20179:20 amRNSCancellation of Lapsed Performance Rights
6th Feb 20177:00 amRNSRevised Securities Dealing Policy
31st Jan 20177:00 amRNSAppendix 5B
31st Jan 20177:00 amRNSQuarterly Activities Report
30th Dec 20168:10 amRNSCleansing Notice Letter
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSAppendix 3B
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:09 amRNSIssue of Equity and Change of Directors' Interests
22nd Dec 20161:15 pmRNSIssue of Equity and Change of Directors' Interests
22nd Dec 20167:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.